Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Common Phar Terms
Common Pharmacy Terminology
| Term | Definition |
|---|---|
| Standing order | An order that may be filled or administered at regularly scheduled intervals |
| Dispense as Written (DAW) | A method prescribers use to indicate the brand name of a product |
| Medication Therapy Management (MTM) | A distinct service or group of services that optimize therapeutic outcomes for individual patients |
| A date that reflects the maximum time the product is guaranteed to remain stable if stored properly. If an expiration date is listed with only month and year | |
| Expiration date | A date that reflects the maximum time the product is guaranteed to remain stable if stored properly. If an expiration date is listed with only month and year |
| p.r.n. order | An order that may be filled or administered upon patient/prescriber request |
| BIN | A number that identifies an insurance provider |
| PCN | A secondary number for routing insurance claims |
| GRP | A number that identifies the employer through which the insurance is provided |
| Unit dose package | A package that contains the amount of drug required for a single dose. Often medications in institutional settings are unit dosed |
| Formulary | A list of medications that have been selected (e.g. |
| Dosage form | The physical manifestion of the medication (e.g. capsule |
| National Provider Identifer (NPI) | A unique 10-digit identification number for covered health care providers; typically used for billing purposes |
| 70% isopropyl alcohol | Common cleaning agent |
| Boxed warning | Information on a legend drug label calling attention to serious or life-threatening risks |
| Drug interaction | When a medication's effect on the body is changed by another drug |
| Beyond-use date (BUD) | The date assigned to a compounded or repackaged medication to indicate when to discard to product. Beyond-use date considerations include contamination risk and storage conditions |
| Therapeutic window | The range of drug dosages that can treat disease effectively without having toxic effects |
| Systemic effect | The distribution of a medication throughout the body by absorption into the bloodstream |
| Prior authorization | A requirement by health plans for patients to obtain approval of a health care service or medication before the care is provided. This allows the plan to evaluate whether care is medically necessary and otherwise covered. |
| Drug class | A group of medications and other compounds that have similar chemical structures |
| signa (sig) | The part of the prescription that provides the directions for the patient to follow when taking the medication |
| Look-alike/sound-alike (LASA) medications | Medication names that look alike when written or sound alike when spoken |
| Maximum allowable cost (MAC) | The maximum amount a pharmacy benefits manager (PBM) will reimburse for a specific generic drug available from multiple manufacturers and sold at different prices |
| Contraindication | Situation in which a drug should absolutely not be used because the risk clearly outweighs the benefit; reasons include allergies |
| Deductible | A set amount that must be paid by the patient for each benefit period prior to the insurer covering additional expenses |
| Drug Utilization Review (DUR) | An ongoing examination of the prescribing |
| Preferred provider organization (PPO) | A type of health plan that contracts with medical providers to create a network of participating providers. Coverage is provided to participants through the network of healthcare providers |
| Protected health information (PHI) | Any personal information that could be used to identify an individual to their health history |
| Tall Man lettering (TML) | A technique that uses uppercase lettering to help differentiate look-alike drug names. The FDA and the ISMP both maintain lists of drugs with recommended Tall Man lettering |
| Aseptic technique | |
| Roman numerals | A numeral system originating in Rome where letters from the Latin alphabet are used to express numerical values |
| Off-label use | A practice of prescribing a medication for a different purpose than what the FDA approved |
| Adverse drug event (ADE) | Injury or harm that occurs as a result of exposure to a medication |
| Brand name or proprietary drug | A drug sold by a drug company under a specific name or trademark and that is protected by a patent |
| Pharmacy benefits manager (PBM) | A third-party company that administers prescription drug programs |
| Medication nonadherence | When a patient does not take a prescribed medication or follow the prescriber's instructions for taking the medication |
| Co-pay | A portion of the prescription price the patient is required to pay |
| Narrow therapeutic index (NTI) drug | A drug where small differences in dose or blood concentration may lead to serious therapeutic failures and/or adverse drug reactions |
| Electronic Medical Record (EMR) | A computerized patient medical record |
| Generic medication | A medication that contains the same active ingredient(s) as the brand name product and delivers the same amount of medication to the body for a similar medicinal effect |
| Route of administration | The way by which a drug is taken into the body. Common routes of administration include oral |
| Therapeutic equivalent | A generic drug product that contains identical amounts of the same active ingredient(s) as the brand name product and is available in the same dosage form |
| STAT order | An order for medication to be administered immediately |
| ASAP order | A hospital order that needs to be processed as soon as possible |
| Warning labels | Labels that identify specific warnings |
| Dual co-pay | Co-pays that have two prices |
| MedWatch | The FDA’s medical product safety reporting program for health professionals |
| Enteral route of administration (ROA) | A ROA to any organ in the alimentary tract |
| Par level | The minimum amount of inventory needed on hand to meet known demand and a small surplus in case of unexpected demand |
| National Drug Code (NDC) number | A 10- or 11-digit number assigned to drug products that represents the manufacturer/labeler |
| Proper medication storage | The correct temperature range |
| Institute for Safe Medication Practices (ISMP) | A nonprofit organization that provides impartial |
| Drug Utilization Review (DUR) warning | An alert or message generated by pharmacy or insurance company software notifying pharmacy personnel of a potential drug safety or payment concern |
| High-alert/risk medications | Medications that have a heightened risk of causing significant harm if used in error |
| Computerized provider order entry (CPOE) | A process that requires providers to enter and send treatment instructions via computer application rather than paper |
| Medication categories | Legend (requires a prescription) and OTC (over-the-counter) |
| Parenteral administration | The delivery of a medication that bypasses the digestive tract. Parenteral routes of administration include subcutaneous |
| Medication error | Any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the healthcare professional |
| Vaccine Adverse Event Reporting System (VAERS) | A vaccine adverse event reporting system co-managed by the CDC and the FDA. VAERS is used as a national early warning system to detect possible safety problems with licensed vaccines |
| c | Unwanted or unexpected effect possibly related to a particular medication; also known as side effect |
| Days supply | How many days a prescription will last if the patient uses it as directed |
Created by:
pharmacology001
Popular Pharmacology sets